MGMT promoter methylation in Peruvian patients with glioblastoma

PURPOSE: O(6)-methylguanine–DNA methyltransferase (MGMT) promoter methylation predicts the outcome and response to alkylating chemotherapy in glioblastoma. The aim of this study is to evaluate the prevalence of MGMT methylation in Peruvian glioblastoma cases. PATIENTS AND METHODS: We evaluated retro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ecancermedicalscience
Autores principales: Belmar-Lopez, Carolina, Castaneda, Carlos A, Castillo, Miluska, García-Corrochano, Pamela, Orrego, Enrique, Meléndez, Barbara, Casavilca, Sandro, Flores, Claudio
Formato: Artigo
Lenguaje:Inglês
Publicado: Cancer Intelligence 2018
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834313/
https://ncbi.nlm.nih.gov/pubmed/29515653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.812
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares